Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tarsus Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
TARS
Nasdaq
2834
www.tarsusrx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tarsus Pharmaceuticals, Inc.
Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
- Feb 4th, 2025 1:49 pm
Tarsus to Participate in Upcoming Investor Conferences
- Jan 30th, 2025 10:00 pm
CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?
- Jan 23rd, 2025 1:30 pm
Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
- Jan 20th, 2025 8:31 pm
Down -9.11% in 4 Weeks, Here's Why Tarsus Pharmaceuticals (TARS) Looks Ripe for a Turnaround
- Jan 14th, 2025 2:35 pm
Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
- Jan 13th, 2025 1:30 pm
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?
- Jan 8th, 2025 11:09 am
How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run
- Dec 26th, 2024 3:30 pm
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex
- Dec 26th, 2024 2:48 pm
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
- Dec 24th, 2024 4:49 pm
Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet
- Dec 4th, 2024 2:55 pm
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade
- Nov 18th, 2024 2:55 pm
Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
- Nov 15th, 2024 1:38 pm
Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
- Nov 14th, 2024 7:15 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Tops Revenue Estimates
- Nov 13th, 2024 10:30 pm
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
- Nov 13th, 2024 9:05 pm
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
- Nov 13th, 2024 1:30 pm
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Nov 7th, 2024 3:00 pm
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
- Nov 6th, 2024 9:30 pm
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
- Nov 5th, 2024 1:30 pm
Scroll